文献速递妇科产科

将妇科肿瘤诊疗扩展至小城市及农村对卵巢癌患者的影响

The impact of expanding gynecologic oncology care to ovarian cancer patients in small cities and rural communities.
PubMed 文献 · Gynecol Oncol · 2021-04-20

本研究利用地方肿瘤登记数据,比较小城市及周边农村社区在建立全职妇科肿瘤(GO)办公室前后卵巢癌患者的管理策略、结局和就医可及性。共381例患者,建立后手术由GO专家实施、本地手术、完整淋巴结清扫及GO化疗的比例均显著提高,5年生存率从33.8%升至49.5%,中位生存期从30.8个月延长至52.5个月,手术出行距离均值从47.9英里降至26.8英里。

要点

  • 建立全职GO办公室后,GO专家手术比例从53.2%升至97.1%。
  • 5年生存率从33.8%提高至49.5%,中位生存期从30.8个月延长至52.5个月。
  • 本地手术比例从43.3%升至79.0%,手术出行距离均值从47.9英里降至26.8英里。

核心结论

  • 在小城市建立全职妇科肿瘤办公室后,当地卵巢癌患者的总生存期和就医可及性显著改善。
  • 结果提示将妇科肿瘤诊疗扩展至小城市及周边农村社区具有获益,可用于应对全国女性公共卫生差异。

研究设计与样本

  • 利用地方肿瘤登记数据识别建立全职GO办公室前后诊断的卵巢癌患者。
  • 共纳入381例患者,其中建立前(pre-GO)171例,建立后(post-GO)210例。
  • 采用定量分析比较两队列的疾病特征、管理策略、总生存期和就医出行距离。

主要发现

  • post-GO组由GO专家实施手术的比例为97.1%,pre-GO组为53.2%(p < 0.01)。
  • post-GO组在本地接受手术的比例为79.0%,pre-GO组为43.3%(p < 0.01)。
  • post-GO组接受完整淋巴结清扫的比例为63.3%,pre-GO组为38.6%(p < 0.01)。
  • 由GO实施化疗的比例从pre-GO的10.3%增至post-GO的76.9%。
  • 5年生存率pre-GO组为33.8%,post-GO组为49.5%(p < 0.01);中位生存期从30.8个月延长至52.5个月。

临床怎么用

  • 小城市及农村社区可通过建立全职妇科肿瘤办公室,提高卵巢癌患者接受GO专家手术和化疗的比例。
  • 该模式可增加本地手术比例并缩短手术出行距离,改善就医可及性。
  • 该模式与卵巢癌患者总生存期改善相关,可作为缩小地区诊疗差异的参考策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with ovarian cancer from smaller cities and rural communities face unique challenges in accessing comprehensive care. This study compares management strategies, outcomes, and access to care for patients in a small city and surrounding rural communities before and after establishing a full-time gynecologic oncology (GO) office. METHODS: A local tumor registry was used to identify patients diagnosed with ovarian cancer before and after a full-time GO office was established. Quantitative analyses were used to compare disease characteristics, management strategies, overall survival, and distance traveled for care between cohorts. RESULTS: Out of 381 patients, 171 women were diagnosed prior to establishing a full-time GO office (pre-GO) and 210 after (post-GO). Post-GO patients were more likely to undergo surgery by a GO specialist (97.1% versus 53.2%, p < 0.01), receive surgery locally (79.0% versus 43.3%, p < 0.01), and undergo complete lymph node dissection (63.3% versus 38.6%, p < 0.01). Patients treated with chemotherapy by GO increased from 10.3% pre-GO to 76.9% post-GO. 5-year survival rates were 33.8% versus 49.5% in the pre-GO and post-GO groups, respectively (p < 0.01). Median survival time increased from 30.8 months to 52.5 months from pre-GO to post-GO time periods. Distance patients traveled for surgery decreased from a mean of 47.9 miles pre-GO to 26.8 miles post-GO. CONCLUSION: After establishing a full-time GO office within a small city, local patients had significantly improved overall survival and access to care. These results highlight the benefit of expanding GO care into small cities with surrounding rural communities and may be used to address public health discrepancies for women across the country.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Swayze EJ, Strzyzewski L, Avula P, et al. The impact of expanding gynecologic oncology care to ovarian cancer patients in small cities and rural communities. Gynecol Oncol. 2021. PMID: 33888339. doi:10.1016/j.ygyno.2021.04.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。